Posted by Jason Zweig on Mar 30, 2015 in Blog, Featured, Posts |Image credit: Genetically modified Amflora cells, BASF, flickr Creative CommonsBy Jason Zweig11:17 am ET Mar. 27, 2015In a research note out today, Credit Suisse analysts Ravi Mehrotra, Jason Kantor, Anuj Shah and Jeremiah Shepard write that biotechnology stocks are not in a bubble but “rather in a new […]
Benchmarks ended the last trading session of the week on a positive note after Fed Chair Janet Yellen said there was a possibility of a gradual hike in interest rates sometime this year. The Nasdaq was boosted by a possible deal between Intel and Altera. Gains in bio-tech stocks also helped the Nasdaq end in positive territory. However, benchmarks reported […]
View gallery.(Wikimedia Commons)There is probably a bubble in biotech stocks.
In a big note on published on Friday, analysts at Credit Suisse ask if we’re in a biotech bubble, and answer that no, it’s not a bubble, merely a “new era” for biotech stocks. Which is exactly what it sounds like when something is a bubble. Credit Suisse hinges its argument on what […]
Wikimedia CommonsThere is probably a bubble in biotech stocks. In a big note on published on Friday, analysts at Credit Suisse ask if we’re in a biotech bubble, and answer that no, it’s not a bubble, merely a “new era” for biotech stocks. Which is exactly what it sounds like when something is a bubble. Credit Suisse hinges its argument on what it […]
Related ATHXMorning Market GainersWhy Investors Are Watching Athersys Ahead Of Stem Cell DataIn a recent report, analysts at Maxim Group discussed the biotechnology sector and gave their outlook for five names in the space. Here’s a rundown of what they had to say.Athersys, Inc. (NASDAQ: ATHX)Analysts believe that Athersys may have found a “sweet spot” for stroke treatment timing, as […]
Capitalist Bull: Price Action Impressive Volume Not So Much
PagesHome
Leading Growth Stocks Analysis
Short Trading Ideas
SERVICES
Newsletter Sign Up
Interviews
About Us
Disclaimer
Price Action Impressive Volume Not So MuchMarket price action has been impressive by any respect. Despite persistent bad news from around the world, and numerous internal red flags, the NYSE advance decline line continues to trade near new highs, and the market marches higher […]
This post is an update to various past posts concerning the stock market bubble, most recently that of November 21, 2013 titled “Is The Stock Market Experiencing A Bubble?”Many people don’t believe that we are currently experiencing a stock market bubble because their primary reference regarding stock market bubbles is that of the mid- to late-1990s, in which there was […]
SummaryHot = near-term stock price gain potential, not just product developments, lab breakthroughs, corporate acquisitions, financing deals, trial progresses etc.
Only opinions; not even “just the facts, m’aam”. But opinions expressed by folks who need to know, willing to put their money at risk, based on what they know.
Maybe even better, ones who are willing to pay up for price-change risk […]
View gallery.Rumor has it that if the S&P 500 finishes its first five trading days of the year with a gain, then the year in question will — 80 percent of the time — end with a gain as well.Last Thursday’s rally gave the S&P that five-day gain. However, since that day, the market has seen a decent amount of […]
CIA Economist Warns of Stock Market CrashPosted by: : Shayne HeffernanPosted on: January 10, 2015CIA Economist Warns of Stock Market CrashMount Weather is a national security stronghold located near the Blue Ridge Mountains.Its maze of underground bunkers is known as “Area B.”My colleagues have given Mount Weather the code name “High Point Special Facility.”This is where Congressional leadership was transported […]
